Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer

Lcn2 overexpression in metastatic breast cancer (MBC) can lead to cancer progression by inducing the epithelial-to-mesenchymal transition and enhancing tumor angiogenesis. In this study, we engineered a PEGylated liposomal system encapsulating lipocalin 2 (Lcn2) small interfering RNA (Lcn2 siRNA) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gote, Vrinda, Pal, Dhananjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067132/
https://www.ncbi.nlm.nih.gov/pubmed/33916786
http://dx.doi.org/10.3390/bioengineering8040044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067132/
https://www.ncbi.nlm.nih.gov/pubmed/33916786
http://dx.doi.org/10.3390/bioengineering8040044

Ejemplares similares